Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) EBITDA (2023 - 2026)

Updated

Genmab A (GMAB) posted EBITDA of $401 million for the quarter ended Jun 30, 2026, up 91.9% from the prior quarter.

Analysis

Genmab A (GMAB) EBITDA (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA at Genmab A was $943 million; for the year ended Dec 31, 2025, it came in at $1.14 billion, up 10.1% from the prior year.

  • In prior years, Genmab A's EBITDA was $1.03 billion in the year ended Dec 31, 2024 (+26.6%) and $815 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 13.33 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 8.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 8.16 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 7.37 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 4.20 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 7.05 Bn
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 458.00 Mn
Jun 30, 2026 401.00 Mn
Mar 31, 2026 209.00 Mn
Mar 31, 2025 204.00 Mn
Mar 31, 2024 129.00 Mn
Dec 31, 2023 -2.99 Bn
API Access

Genmab A EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=GMAB&period=max&api_key=YOUR_API_KEY